Effects of Pea Proteins With Different Degrees of Processing on Postprandial Metabolism in Healthy Adults
Acute Effects of Pea Proteins With Different Degrees of Processing on Postprandial Metabolism in Healthy Women and Men
1 other identifier
interventional
20
1 country
1
Brief Summary
The aim of this study is to investigate the postprandial metabolic responses to plant-based protein ingredients of different degrees of processing (pea protein concentrate, isolate, and extrudate) and in comparison to whey protein in healthy adults. Therefore, young healthy subjects consume 4 test meals with 25 g of protein from pea protein concentrate, pea protein isolate, pea protein extrudate or whey protein in a randomized order. In a postprandial period of 6 hours, parameters of protein and glucose metabolism (i.a. plasma amino acids), gastric emptying and hunger/satiety are analysed. It is assumed that the plasma amino acid profile after plant protein ingestion differs depending on processing level of the protein ingredients and in comparison to whey protein.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2023
CompletedFirst Posted
Study publicly available on registry
December 4, 2023
CompletedStudy Start
First participant enrolled
January 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2024
CompletedApril 23, 2025
April 1, 2025
5 months
November 7, 2023
April 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Amino acid profile in blood
Analysis of amino acid profile in plasma (nmol/ml)
Postprandial period of 5 hours (Time points: fasting (0) and 15, 30, 45, 60, 90, 120, 180, 240 and 300 minutes)
Secondary Outcomes (12)
Parameters of protein metabolism in blood I
Postprandial period of 5 hours (Time points: fasting (0) and 30, 60, 90, 120, 180, 240 and 300 minutes)
Parameters of protein metabolism in blood II
Postprandial period of 5 hours (Time points: fasting (0) and 60, 120, 180, 240 and 300 minutes)
Parameters of glucose metabolism in blood I
Postprandial period of 5 hours (Time points: fasting (0) and 30, 60, 90, 120, 180, 240 and 300 minutes)
Parameters of glucose metabolism in blood II
Postprandial period of 5 hours (Time points: fasting (0) and 30, 60, 90, 120, 180, 240 and 300 minutes)
Gastric emptying rate
Postprandial period of 5 hours (Time points: fasting (0) and 30, 60, 90, 120, 180, 240 and 300 minutes)
- +7 more secondary outcomes
Study Arms (4)
Pea concentrate
EXPERIMENTALParticipants randomized to receive a soup containing 25 g of protein from pea protein concentrate
Pea isolate
EXPERIMENTALParticipants randomized to receive a soup containing 25 g of protein from pea protein isolate
Pea extrudate
EXPERIMENTALParticipants randomized to receive a soup containing 25 g of protein from pea protein extrudate
Whey
ACTIVE COMPARATORParticipants randomized to receive a soup containing 25 g of protein from whey protein
Interventions
Ingestion of a soup containing 25 g of protein from pea protein concentrate
Ingestion of a soup containing 25 g of protein from pea protein isolate
Ingestion of a soup containing 25 g of protein from pea protein extrudate
Eligibility Criteria
You may qualify if:
- non-smoking
- metabolically healthy
- normal weight (BMI: 18,5 - 24,9 kg/m2)
- written informed consent
You may not qualify if:
- pregnancy, lactation
- hypo- or hypertension
- underweight or overweight/obesity
- food intolerances and allergies (especially milk protein, pea, celery)
- malabsorption syndromes
- gastrointestinal diseases
- thyroid diseases
- diabetes mellitus type 1 and type 2
- impaired kidney or liver function
- anaemia
- blood coagulation disorders
- irregular menstrual cycle
- endometriosis, severe menstrual problems
- hormonal contraception
- regular use of medications (especially habitual use of paracetamol or medications that may interact with paracetamol)
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Bonn
Bonn, 53115, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Egert, Prof PhD
Germany University of Bonn
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sarah Egert, Prof PhD
Study Record Dates
First Submitted
November 7, 2023
First Posted
December 4, 2023
Study Start
January 22, 2024
Primary Completion
June 28, 2024
Study Completion
June 28, 2024
Last Updated
April 23, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share